Management of Elevated Blood Pressure in Elderly Females

Blood Pressure Target

The American College of Cardiology recommends a systolic blood pressure target of <130 mmHg in noninstitutionalized, ambulatory, community-dwelling adults ≥65 years of age, with a Class I, Level A recommendation 1, 2, 3
Intensive blood pressure control safely reduces cardiovascular morbidity and mortality without increasing falls or orthostatic hypotension in elderly patients, as demonstrated by landmark trials including SPRINT and HYVET 1, 2, 3
Older women specifically benefit from systolic blood pressure control <140 mmHg, with stroke reduction being the primary driver of cardiovascular benefit in this population 4

The American College of Cardiology suggests that calcium channel blockers, such as amlodipine, are particularly effective for isolated systolic hypertension, which is the predominant form in elderly women 1, 2, 3
Amlodipine-based therapy reduced cardiovascular events by 17% compared to atenolol-based therapy in patients ≥65 years, with absolute benefits greater in older patients due to higher baseline event rates 5
The combination of an ARB (losartan) with a calcium channel blocker (amlodipine) is evidence-based, as demonstrated by the ACCOMPLISH trial showing efficacy of ACE inhibitor-calcium antagonist combinations in elderly hypertensive patients 4

The American College of Cardiology recommends measuring blood pressure in both sitting and standing positions at every visit to assess orthostatic hypotension, which is a significant concern in elderly patients 1, 2, 3, 5
Schedule follow-up within 2-4 weeks after increasing amlodipine to assess response and monitor for adverse effects, and implement home blood pressure monitoring with a target of <135/85 mmHg to confirm adequate control between visits 5, 6

Avoid reducing diastolic blood pressure below 60-70 mmHg, as this may compromise coronary perfusion if coronary heart disease is present 5
Gradual titration over weeks is safer than aggressive acute reduction in elderly patients to minimize adverse effects 6

No randomized trial of blood pressure lowering in persons >65 years has ever shown harm or less benefit for older versus younger adults 1, 2, 3
Elderly women, who comprise the majority of the elderly hypertensive population, should be treated to <140 mmHg based on trials like SHEP showing significant stroke reduction 4

The American College of Cardiology advises against accepting suboptimal dosing, and recommends increasing the amlodipine dose to the standard therapeutic dose before adding additional agents 1, 2, 3
Do not use age alone as a reason to accept higher blood pressure targets, as community-dwelling elderly patients benefit from the same intensive targets as younger patients 1, 2, 3
Do not discontinue successful therapy if the patient turns 80 years old, as there is no reason to stop effective treatment based solely on reaching a specific age milestone 6